Clinical review: Influence of vasoactive and other therapies on intestinal and hepatic circulations in patients with septic shock

Critical Care

Volumn 8, Issue 3, 2004, Pages 170-179

  Asfar, Pierre ^a   De Backer, Daniel ^b   Meier Hellmann, Andreas ^c   Radermacher, Peter ^d   Sakka, Samir G ^e  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b ERASME HOSPITAL   (Belgium)

^c HELIOS KLINIKUM ERFURT   (Germany)

^d UNIVERSITY HOSPITAL ULM   (Germany)

^e FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Adrenergic drugs; Nonconventional treatments; Septic shock; Splanchnic circulation; Supportive treatment

Indexed keywords

ACETYLCYSTEINE; ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; ALBUMIN; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE DERIVATIVE; DOBUTAMINE; DOPAMINE; DOPEXAMINE; ENOXIMONE; GELATIN; GLYCERYL TRINITRATE; HETASTARCH; HYPERTENSIVE AGENT; ILOPROST; NORADRENALIN; PHENYLEPHRINE; PROSTACYCLIN; TERLIPRESSIN; VASOPRESSIN;

AUTONOMIC NERVOUS SYSTEM; CLINICAL TRIAL; DRUG EFFECT; ERYTHROCYTE TRANSFUSION; EXTRACORPOREAL CIRCULATION; FLUID THERAPY; HEMODYNAMICS; HUMAN; INFLAMMATION; INTESTINE BLOOD FLOW; INTESTINE MUCOSA; LIVER BLOOD FLOW; METABOLIC REGULATION; MICROCIRCULATION; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; REVIEW; SEPSIS; SEPTIC SHOCK; SPLANCHNIC BLOOD FLOW; TACHYCARDIA; TISSUE OXYGENATION;

ACETYLCYSTEINE; FLUID THERAPY; HEMODYNAMIC PROCESSES; HUMANS; INTESTINAL MUCOSA; LIVER; MULTIPLE ORGAN FAILURE; OXYGEN; RESPIRATION, ARTIFICIAL; SHOCK, SEPTIC; SPLANCHNIC CIRCULATION; VASOCONSTRICTOR AGENTS;

EID: 2942559078     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc2418     Document Type: Review

References (82)

1. Carrico CJ, Meakins JL, Marshall JC, Fry D, Maier RV: Multiple organ failure syndrome. The gastrointestinal tract: the 'motor' of MOF. Arch Surg 1986, 121:196-208.
2. Dantzker DR: The gastrointestinal tract. The canary of the body? JAMA 1993, 270:1247-1248.
3. Lautt WW: Mechanism and role of intrinsic regulation of hepatic arterial blood flow: hepatic arterial buffer response. Am J Physiol 1985, 249:G549-G556.
4. Dahn MS, Lange P, Lobdell K, Hans B, Jacobs LA, Mitchell RA: Splanchnic and total body oxygen consumption differences in septic and injuried patients. Surgery 1987, 101:69-80.
5. Uusaro A, Ruokonen E, Takala J: Estimation of splanchnic blood flow by the Fick principle in man and problems in the use of indocyanine green. Cardiovasc Res 1995, 30:106-112.
6. Reilly PM, Wilkins KB, Fuh KC, Haglund U, Bulkley GB: The mesenteric hemodynamic response to circulatory shock: an overview. Shock 2001, 15:329-343.
7. Temmesfeld-Wollbrück B, Szalay A, Mayer K, Olschewski H, Seeger W, Grimminger F: Abnormalities of gastric mucosal oxygenation in septic shock. Am J Respir Crit Care Med 1998, 157:1586-1592.
8. Meier-Hellmann A, Specht M, Hannemann L, Hassel H, Bredle DL, Reinhart K: Splanchnic blood flow is greater in septic shock treated with norepinephrine than in severe sepsis. Intensive Care Med 1996, 22:1354-1359.
9. De Backer D, Creteur J, Silva E, Vincent JL: The hepatosplanchnic area is not a common source of lactate in patients with severe sepsis. Crit Care Med 2001, 29:256-261.
10. 2 gap is associated with impaired villus microcirculation in endotoxic pigs. Intensive Care Med 2001, 15:757-766.
11. Duranteau J, Sitbon P, Teboul JL, Vicaut E, Anguel N, Richard C, Samii K: Effects of epinephrine, norepinephrine or the combination of norepinephrine and dobutamine on gastric mucosa in septic shock. Crit Care Med 1999, 27:893-900.
12. De Backer D, Creteur J, Preiser JC, Dubois MJ, Vincent JL: Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002, 166:98-104.
13. Fink MP: Bench-to-bedside review: Cytopathic hypoxia. Crit Care 2003, 6:491-499.
14. Levy B, Gawalkiewicz P, Vallet B, Briancon S, Nace L, Bollaert PE: Gastric capnometry with air-automated tonometry predicts outcome in critically ill patients. Crit Care Med 2003, 31:474-480.
15. Creteur J, De Backer D, Vincent JL: Does gastric tonometry monitor splanchnic perfusion? Crit Care Med 1999, 27:2480-2484.
16. 2 gradient does not reflect systemic and splanchnic hemodynamics or oxygen transport after cardiac surgery. Shock 2000, 14:13-17.
17. Hollenberg SM, Ahrens TS, Astiz ME, Chalfin DB, Dasta JF, Heard SO, Martin C, Susla GM, Vincent JL: Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Crit Care Med 1999, 27:639-660.
18. Choi PT, Yip G, Quinonez LG, Cook DJ: Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 1999, 27:200-210.
19. Boldt J, Heesen M, Müller M: The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg 1996, 83:254-261.
20. Asfar P, Kerkeni N, Labadie F, Gouello JP, Brenet O, Alquier P: Assessment of hemodynamic and gastric mucosal acidosis with modified fluid gelatin versus 6% hydroxyethyl starch: a prospective randomized study. Intensive Care Med 2000, 26: 1282-1287.
21. Sakka SG, Meier-Hellmann A, Reinhart K: Do fluid administration and reduction in norepinephrine dose improve global and splanchnic haemodynamics? Br J Anaesth 2000, 84:758-762.
22. 2 gradient or gastric intramucosal pH in patients who have sepsis syndrome. Crit Care Med 2000, 28:2254-2258.
23. Shortgen F, Brochard L, Burnham E, Martin GS: Pro/Con clinical debate: Hydroxyethylstarches should be avoided in septic patients. Crit Care 2003, 7:279-281.
24. Silverman H, Tuma P: Gastric tonometry in patients with sepsis: effects of dobutamine infusions and packed red blood cell transfusions. Chest 1992, 102:184-188.
25. Marik PE, Sibbald WJ. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993, 16:3024-3029.
26. Fernandes CJ, Akamine N, De Marco FVC, De Souza JAM, Lagudis S, Knobel E: Red blood cell transfusion does not increase oxygen consumption in critically ill septic patients. Crit Care 2001, 5:362-367.
27. Nevière R, Mathieu D, Chagnon JL Lebleu N, Wattel F: The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in septic patients. Am J Respir Crit Care Med 1996, 154:1684-1688.
28. Meier-Hellmann A, Bredle DL, Specht M, Hannemann L, Reinhart K: The effects of low-dose dopamine on splanchnic blood flow and oxygen uptake in patients with septic shock. Intensive Care Med 1997, 23:31-37.
29. Olson D, Pohlman A, Hall JB: Administration of low-dose dopamine to nonoliguric patients with sepsis syndrome does not raise intramucosal gastric pH not improve creatinine clearance. Am J Respir Crit Care Med 1996, 154:1664-1670.
30. Maynard ND, Bihari DJ, Dalton RN, Smithies MN, Mason RC: Increasing splanchnic blood flow in the critically ill. Chest 1995, 108:1648-1654.
31. Jakob SM, Ruokonen E, Takala J: Effects of dopamine on systemic and regional blood flow and metabolism in septic and cardiac surgery patients. Shock 2002, 18:8-13.
32. Ruokonen E, Takala J, Kari A, Saxén H, Mertsola J, Hansen EJ: Regional blood flow and oxygen transport in septic shock. Crit Care Med 1993, 21:1296-1303.
33. Ruokonen E, Takala J, Uusaro A: Effect of vasoactive treatment on the relationship between mixed venous and regional oxygen saturation. Crit Care Med 1991, 19:1365-1369.
34. Marik PE, Mohedin M: The contrasting effects of dopamine and norepinephrine on systemic and splanchnic oxygen utilization in hyperdynamic sepsis. JAMA 1994, 272:1354-1357.
35. De Backer D, Creteur J, Silva E, Vincent JL: Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is the best? Crit Care Med 2003, 31: 1659-1667.
36. Gutierrez G, Clark C, Brown SD, Price K, Ortiz L Nelson C: Effects of dobutamine on oxygen consumption and gastric mucosal pH in septic patients. Am J Respir Crit Care Med 1994, 150:324-329.
37. Zhou SX, Qiu HB, Huang YZ, Yang Y, Zheng RQ: Effects of norepinephrine, epinephrine, norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock. Acta Pharmacol Sin 2002, 23:654-658.
38. Levy B, Nace L, Bollaert PE, Dousset B, Mallie JP, Larcan A: Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock. Intensive Care Med 1997, 23: 282-287.
39. Joly LM, Monchi M, Carriou A, Chiche JD, Bellenfant F, Brunet F, Dhainaut JF: Effect of dobutamine on gastric mucosal perfusion and hepatic metabolism in patients with septic shock. Am J Respir Crit Care Med 1999, 160:1983-1986.
40. Ruokonen E, Uusaro A, Alhava E, Takala J: The effect of dobutamine infusion on splanchnic blood flow and oxygen transport in patients with acute pancreatitis. Intensive Care Med 1997, 23:732-737.
41. Creteur J, De Backer D, Vincent JL: A dobutamine test can disclose hepatosplanchnic hypoperfusion in septic patients. Am J Respir Crit Care Med 1999, 160:839-845.
42. Reinelt H, Radermacher P, Fischer G, Geisser W, Wachter U, Wiedeck H, Georgieff M, Vogt J: Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock. Anesthesiology 1997, 86:818-824.
43. De Backer D, Creteur J, Noordally O, Smail N, Gulbis B, Vincent JL: Does hepato-splanchnic VO2/DO2 dependency exist in critically ill patients? Am J Respir Crit Care Med 1998, 157: 1219-1225.
44. Reinelt H, Radermacher P, Kiefer P, Fischer G, Wachter U, Vogt J, Georgieff M: Impact of exogenous beta-adrenergic receptor stimulation on hepatosplanchnic oxygen kinetics and metabolic activity in septic shock. Crit Care Med 1999, 27:325-331.
45. Meier-Hellmann A, Reinhart K, Bredle DL, Specht M, Spies CD, Hannemann L: Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med 1997, 25:399-404.
46. Seguin P, Bellissant E, Le Tulzo Y, Laviolle B, Lessard Y, Thomas R, Malledant Y: Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock. Clin Pharmacol Ther 2002, 71:381-388.
47. Smithies M, Tee TH, Jackson L, Beale R, Bihari D: Protecting the gut and the liver in the critically ill: effects of dopexamine. Crit Care Med 1994, 22:789-795.
48. Hannemann L, Reinhart K, Meier-Hellmann A, Wallenfang G, Bredle DL: Dopexamine hydrochloride in septic shock. Chest 1996, 109:756-760.
49. Meier-Hellmann A, Bredle DL, Specht M, Hannemann L, Reinhart K: Dopexamine increases splanchnic blood flow but decreases gastric mucosal pHi in severe septic patients treated with dobutamine. Crit Care Med 1999, 27:2166-2171.
50. Kiefer P, Tugtekin E, Wiedeck H, Bracht H, Geldner G, Georgieff M, Radermacher P: Effect of a dopexamine-induced increase in cardiac index on splanchnic hemodynamics in septic shock. Am J Respir Crit Care Med 2000, 161:775-779.
51. Kiefer P, Tugtekin I, Wiedeck H, Vogt J, Wachter U, Bracht H, Geldner G, Georgieff M, Radermacher P: Effect of dopexamine on hepatic metabolic activity in patients with septic shock. Shock 2001, 15:427-431.
52. Landry DW, Levin HR, Gallant HM, Ashton RC, Seo S, D'Alessandro D, Oz M, Oliver JA: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997, 95:1122-1125.
53. Oliver JA, Landry DW: Patient with a sudden drop in blood pressure. Crit Care Med 2003, 31:326-327.
54. American Heart Association and International Liaison on Cardiopulmonary Resuscitation: Advanced cardiovascular life support. Pharmacology II: agents to optimize cardiac output and blood pressure. Resuscitation 2000, 46:155-162.
55. Patel BM, Chittock DR, Russell JA, Walley KR: Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002, 96:576-582.
56. Klinzing S, Simon M, Reinhart K, Bredle DL, Meier-Hellmann A: High-dose vasopressin is not superior to norepinephrine in septic shock. Crit Care Med 2003, 31:2646-2650.
57. Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA: Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001, 29:487-493.
58. Landry DW, Levin HR, Gallant EM, Seo S, D'Alessandro D, Oz MC, Oliver JA: Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997, 25:1279-1282.
59. Holmes CL, Walley KR, Chittock DR, Lehman T, Russell JA: The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series. Intensive Care Med 2001, 27:1416-1421.
60. Ryan DW, Kilner AJ: What about vasopressin? Intensive Care Med 2002, 28:810-811.
61. Dünser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, Friesenecker B, Hasibeder WR: Arginine vasopressin in advanced vasodilatory shock. A prospective, randomized, controlled study. Circulation 2003, 107:2313-2319.
62. O'Brien A, Clapp L, Singer M: Terlipressin for norepinephrine-resistant septic shock. Lancet 2002, 359:1209-1210.
63. Westphal M, Bone H-G, Van Aken H, Sielenkämper AW: Terlipressin for haemodynamic support in septic patients: a double-edged sword? Lancet 2002, 360:1250-1251.
64. Auzinger GM, O'Callaghan PG, Harry RA, Wendon JA: Terlipressin in the treatment of catecholamine resistant septic shock [abstract]. Crit Care 2002, Suppl 1:61.
65. Uusaro A, Russell JA: Could anti-inflamatory actions of catecholamines explain the possible beneficial effects of supranormal oxygen delivery in critically ill surgical patients. Intensive Care Med 2000, 26:299-304.
66. Kern H, Schröder T, Kaulfuss M, Martin M, Kox WJ, Spies CD: Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid-optimized septic shock patients. Crit Care Med 2001, 29:1519-1525.
67. Bihari D, Smithies M, Gimson A, Tinker J: The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients. N Engl J Med 1987, 317:397-403.
68. Radermacher P, Buhl P, Santak B, Klein M, Kniemeyer HW, Becker H, Tarnow J: The effects of prostacyclin on gastric intramucosal pH in patients with septic shock. Intensive Care Med 1995, 21:414-421.
69. Eichelbrönner O, Reinelt H, Wiedeck H, Mezödy M, Rossaint R, Georgieff M, Radermacher P: Aerosolized prostacyclin and inhaled nitric oxide in septic shock-different effects on splanchnic oxygenation? Intensive Care Med 1996, 22:880-887.
70. Lehmann C, Taymoorian K, Wauer H, Krausch D, Birnbaum J, Kox WJ: Effects of the stable prostacyclin analogue iloprost on the plasma disappearance rate of indocyanine green in human septic shock. Intensive Care Med 2000, 26:1557-1560.
71. Kiefer P, Tugtekin I, Wiedeck H, Bracht H, Vogt J, Wachter U, Weiss M, Altin C, Georgieff M, Radermacher P: Hepato-splanchnic metabolic effects of the stable prostacyclin analogue iloprost in patients with septic shock. Intensive Care Med 2001, 27:1179-1186.
72. Buwalda M, Ince C: Opening the microcirculation: can vasodilators be useful in sepsis? Intensive Care Med 2002, 28: 1208-1217.
73. Spronk PE, Ince C, Gardien MJ, Mathura KR, Oudemans-van Straaten HM, Zandstra DF: Nitroglycerin in septic shock after intravascular volume resuscitation, Lancet 2002, 360:1395-1396.
74. Spies CD, Reinhart K, Witt I, Meier-Hellmann A, Hannemann L, Bredle DL, Scharffartzik W: Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results of a prospective, randomized, double blind study. Crit Care Med 1994, 22:1738-1746.
75. Rank N, Michel C, Haertel C, Lenhart A, Welte M, Meier-Hellmann A, Spies C: N-acetylcycteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double blind study. Crit Care Med 2000, 28:3799-3807.
76. Reinhart K, Spies CD, Meier-Hellmann A, Bredle DL, Hannemann L, Specht M, Schaffartzik W: N-acetylcysteine preserves oxygen consumption and gastric mucosal pH during hyperoxic ventilation. Am J Respir Crit Care Med 1995, 151:773-779.
77. Peake SL, Moran JL, Leppard PI: N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock. Crit Care Med 1996, 24:1302-1310.
78. Molnár Z, Shearer E, Lowe D: N-acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective, randomized, placebo-controlled study. Crit Care Med 1999, 27:1100-1104.
79. Van der Schueren G, Diltoer M, Laureys M, Huyghens L: Intermittent dialysis in critically ill patients with multiple organ dysfunction syndrome is assossiated with intestinal intramucosal acidosis. Intensive Care Med 1996, 22:747-751.
80. Jakob SM, Ruokonen E, Vuolteenaho O, Lampainen E, Takala J: Splanchnic perfusion during hemodialysis: evidence for marginal tissue perfusion. Crit Care Med 2001, 29:1393-1398.
81. John S, Griesbach D, Baumgärtel M, Weihprecht H, Schmieder RE, Geiger H: Effects of continuous haemofiltration vs intermittent haemodialysis on systemic haemodynamics and splanchnic regional perfusion in septic shock patients: a prospective, randomized clinical trial. Nephrol Dial Transplant 2001, 16:320-327.
82. Davenport A, Will EJ, Davison AM: Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med 1993, 21:328-338.